Publication | Closed Access
Novel Immunosuppression
34
Citations
37
References
2008
Year
R348 is a promising novel JAK3/Syk-inhibitor with favorable pharmacokinetics and biological activity. It effectively diminishes acute cardiac allograft rejection and is suitable for combination regimens with tacrolimus.
| Year | Citations | |
|---|---|---|
Page 1
Page 1